Countries like India and Brazil which had reached high levels of indigenisation began to have their battles with drug ... development. Each chapter deals with one aspect of patents and leads ...

Jindal served as governor of Louisiana and as a U.S. assistant secretary of Health and Human Services. Katebi is deputy director of the Center for a Healthy America at the America First Policy ...

03/24 Import Spring 2026 schedule from PeopleSoft to Ad Astra. Initiate Room Scheduling Optimization* *No PeopleSoft and Ad Astra access from 03/24 – 03/28. 03/28 ...

This review will illustrate several under-discussed key considerations in targeted protein degradation drug discovery and development: 1) the contributing factors for the selectivity of PROTAC ...

This innovative intersection of technology and healthcare addresses the complexities of identifying novel therapeutic compounds, accelerating the drug development timeline, and optimizing the success ...

But other measures are also being examined and one notion the Canadian government should consider is suspending patent rights held by U.S. companies, including pharmaceutical companies ...

This capability has the potential to accelerate the drug development timeline significantly while also reducing costs through automation and enhanced operational efficiency. Overall, the integration ...

Read full article: Texas Senator John Cornyn discusses fentanyl battle, recession concerns during interview with KSAT Homer Idrogo, 51, died of blunt force injuries, according to the ME’s office ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Called evergreening, NGOs had said these companies tend to “extend” drug patent just before the 20-year expiry period by making only a slight modification. Already a subscriber? Log in .

Medicines Patent Pool, a non-governmental organisation that is backed by the United Nations and supports access to drug treatment through a voluntary licensing mechanism for low- and middle ...